Overview:
With the current standard of care, the majority of patients with percutaneous T-cell lymphoma (PTCL) either do not have a complete response or relapse after their therapy is completed. To optimize outcomes for patients with PTCL subtypes, there is a need for educational programs focused on improving prompt and accurate diagnosis and integrating recent efficacy and safety data on current and emerging therapies into clinical practice.
In this dynamic tumor board online
program, expert faculty address these issues and guide structured discussions
on the latest evidence surrounding the diagnosis and management of PTCL.
Through education, clinicians will be better equipped to provide quality care
and optimize outcomes for their patients with PTCL.
Learning Objectives:
Upon completion of this activity, participants will be able to:
- Apply current guidelines to accurately diagnose and classify patients with PTCL
- Evaluate efficacy and safety data from clinical trials investigating novel agents and regimens to personalize treatment plans for PTCL patients
- Incorporate strategies into the PTCL patient’s treatment regimen to mitigate and monitor treatment-related adverse events
Alison J. Moskowitz, MD
Associate Attending Physician, Lymphoma Service
Memorial Sloan Kettering Cancer Center
New York, NY
Francine Foss, MD
Professor of Medical Oncology
Yale Cancer Center
Yale University School of Medicine
New Haven, CT
Sanam Loghavi, MD
Associate Professor
Department of Hematopathology
The University of Texas MD Anderson Cancer Center
Houston, TX
Neha Mehta-Shah, MD, MSCI
Associate Professor of Medicine
Department of Medicine
Division of Oncology
Washington University School of Medicine in St. Louis
St. Louis, MO
Physicians’ Education Resource®, LLC, is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Physicians’ Education Resource®, LLC, designates this live activity for a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Physicians’ Education Resource®, LLC, is approved by the California Board of Registered Nursing, Provider #16669, for 1.5 Contact Hours.